12 studies found for:    20610543 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Rapid Autopsy and Procurement of Non-Small Cell Lung Cancer Tissue
Condition: Non- Small Cell Lung Cancer
Intervention:
2 Recruiting Cabozantinib for Adults With Advanced Soft Tissue Sarcoma
Condition: Refractory Soft Tissue Sarcomas
Intervention: Drug: Cabozantinib
3 Unknown  Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device
Condition: Lung Cancer
Intervention: Device: Biophotonic platform for VOC detection
4 Recruiting Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Eovist;   Procedure: MRI Scan;   Procedure: Percutaneous needle biopsy
5 Unknown  Evaluating the Pulmonary Nodule With Imaging and Biomarkers
Condition: Lung Cancer
Intervention: Device: Olympus Ultrathin Bronchofibervideoscope (XP260F)
6 Active, not recruiting TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
Conditions: Urothelial Carcinoma;   Ureteral Neoplasms;   Ureter Cancer;   Neoplasm, Ureteral;   Cancer of the Ureter
Intervention: Drug: TRC105
7 Recruiting Confusion in the Elderly After Colon Surgery
Conditions: Confusion;   Inflammation;   Acute Phase Reaction;   Surgery;   Delirium
Intervention:
8 Recruiting Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan
Condition: Head and Neck Neoplasms
Intervention:
9 Enrolling by invitation On-site Cytopathology EUS-FNA
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer
Interventions: Procedure: EUS-guided FNA performed with on-site Cytopathologist;   Procedure: EUS-guided FNA performed without on-site Cytopathologist
10 Recruiting Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Conditions: Gastrointestinal Neoplasms;   Cancer of Gastrointestinal Tract;   Cancer of the Gastrointestinal Tract;   Gastrointestinal Cancer;   Neoplasms, Gastrointestinal
Intervention:
11 Recruiting First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
Condition: Sarcoma, Synovial
Interventions: Drug: OTSA101-DTPA-90Y level 1;   Drug: OTSA101-DTPA-90Y level 2;   Drug: OTSA101-DTPA-90Y level 3
12 Recruiting Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Cabozantinib;   Drug: Docetaxel;   Drug: Prednisone

Indicates status has not been verified in more than two years